| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vascular Biology |
From the Department of Cardiovascular Medicine, University of Tokyo, Graduate School of Medicine, Tokyo, and Precursory Research for Embryonic Science and Technology (M.S.), Japan Science and Technology Corporation, Kawaguchi, Japan.
Correspondence to Dr Masataka Sata, Department of Cardiovascular Medicine, University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan. E-mail msata-circ{at}umin.ac.jp
Objective It has been suggested that deregulated expression of the tumor suppressor protein p53 may play a role in the pathogenesis of occlusive vascular remodeling. However, the role of p53 in cell proliferation and apoptosis in vascular lesions has been controversial.
Methods and Results We tested the potential involvement of p53-mediated molecular signaling in lesion formation using a mouse model of vascular injury that may resemble balloon angioplasty. A large wire was inserted into the femoral artery of p53+/+ and p53-/- mice. There was no significant difference in the occurrence of rapid-onset apoptosis, that is, 4 hours after injury. At 2 weeks, the number of proliferating cells in the lesion of p53-/- mice was significantly higher than that observed in p53+/+ mice. The frequency of apoptotic cells was significantly lower in p53-/- mice than in p53+/+ mice. At 4 weeks, the neointimal hyperplasia of p53-/- mice was greater than that of p53+/+ mice. There was no significant difference in the frequency of apoptosis in the lesions.
Conclusions These results indicate a crucial role of p53 in pathological vascular remodeling after mechanical injury and provide the basis for the development of new therapies targeting p53 for a prophylactic treatment of vascular diseases.
Key Words: angioplasty apoptosis balloon injury muscle, smooth atherosclerosis
This article has been cited by other articles:
![]() |
T. Suzuki, D. Sawaki, K. Aizawa, Y. Munemasa, T. Matsumura, J. Ishida, and R. Nagai Kruppel-like Factor 5 Shows Proliferation-specific Roles in Vascular Remodeling, Direct Stimulation of Cell Growth, and Inhibition of Apoptosis J. Biol. Chem., April 3, 2009; 284(14): 9549 - 9557. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Yokoyama, S. Minamisawa, H. Quan, T. Akaike, M. Jin, K. Otsu, C. Ulucan, X. Wang, E. Baljinnyam, M. Takaoka, et al. Epac1 is upregulated during neointima formation and promotes vascular smooth muscle cell migration Am J Physiol Heart Circ Physiol, October 1, 2008; 295(4): H1547 - H1555. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Sanz-Gonzalez, L. Barquin, I. Garcia-Cao, M. Roque, J. M. Gonzalez, J. J. Fuster, M. T. Castells, J. M. Flores, M. Serrano, and V. Andres Increased p53 gene dosage reduces neointimal thickening induced by mechanical injury but has no effect on native atherosclerosis Cardiovasc Res, September 1, 2007; 75(4): 803 - 812. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tanaka, M. Sata, D. Fukuda, Y. Suematsu, N. Motomura, S. Takamoto, Y. Hirata, and R. Nagai Age-Associated Aortic Stenosis in Apolipoprotein E-Deficient Mice J. Am. Coll. Cardiol., July 5, 2005; 46(1): 134 - 141. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Huang, X.-L. Niu, A. M. Pippen, B. H. Annex, and C. D. Kontos Adenovirus-Mediated Intraarterial Delivery of PTEN Inhibits Neointimal Hyperplasia Arterioscler. Thromb. Vasc. Biol., February 1, 2005; 25(2): 354 - 358. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Andres Unexpected Proatherogenic Properties of p21: Beyond Cell Cycle Control? Circulation, December 21, 2004; 110(25): 3749 - 3752. [Full Text] [PDF] |
||||
![]() |
M. Sata and R. Nagai Origin of Neointimal Cells in Autologous Vein Graft Arterioscler. Thromb. Vasc. Biol., July 1, 2004; 24(7): 1147 - 1149. [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |